Biological Assembly 1  

 3D View: Structure | Electron Density | Ligand Interaction

Standalone Viewers  
Protein Workshop | Ligand Explorer

Global Symmetry: Cyclic - C2  (3D View)
Global Stoichiometry: Homo 2-mer - A2 

Biological assembly 1 generated by PISA (software)

Macromolecule Content

• Total Structure Weight: 22421.64 
• Atom Count: 1655 
• Residue Count: 203 
• Unique protein chains: 2

3B7V

HIV-1 protease complexed with gem-diol-amine tetrahedral intermediate NLLTQI

• DOI: 10.2210/pdb3B7V/pdb

• Classification: HYDROLASE/HYDROLASE INHIBITOR
• Organism(s): Human immunodeficiency virus 1, Human immunodeficiency virus type 1 group M subtype B (isolate BH5)
• Expression System: Escherichia coli BL21(DE3)
• Mutation(s): 5 


• Deposited: 2007-10-31 Released: 2007-12-18 
• Deposition Author(s): Kovalevsky, A.Y., Chumanevich, A.A., Weber, I.T.

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 1.46 Å
• R-Value Free: 0.212 

Literature

Caught in the Act: The 1.5 A Resolution Crystal Structures of the HIV-1 Protease and the I54V Mutant Reveal a Tetrahedral Reaction Intermediate.

Kovalevsky, A.Y., Chumanevich, A.A., Liu, F., Louis, J.M., Weber, I.T.

(2007) Biochemistry 46: 14854-14864

• PubMed: 18052235 
• DOI: 10.1021/bi700822g
• Primary Citation of Related Structures:  
  3B80


• PubMed Abstract: 
  

HIV-1 protease (PR) is the target for several important antiviral drugs used in AIDS therapy. The drugs bind inside the active site cavity of PR where normally the viral polyprotein substrate is bound and hydrolyzed. We report two high-resolution crystal structures of wild-type PR (PRWT) and the multi-drug-resistant variant with the I54V mutation (PRI54V) in complex with a peptide at 1.46 and 1.50 A resolution, respectively. The peptide forms a gem-diol tetrahedral reaction intermediate (TI) in the crystal structures. Distinctive interactions are observed for the TI binding in the active site cavity of PRWT and PRI54V. The mutant PRI54V/TI complex has lost water-mediated hydrogen bond interactions with the amides of Ile50 and Ile50' in the flap. Hence, the structures provide insight into the mechanism of drug resistance arising from this mutation. The structures also illustrate an intermediate state in the hydrolysis reaction. One of the gem-diol hydroxide groups in the PRWT complex forms a very short (2.3 A) hydrogen bond with the outer carboxylate oxygen of Asp25. Quantum chemical calculations based on this TI structure are consistent with protonation of the inner carboxylate oxygen of Asp25', in contrast to several theoretical studies. These TI complexes and quantum calculations are discussed in relation to the chemical mechanism of the peptide bond hydrolysis catalyzed by PR.

---

Organizational Affiliation: 

Department of Biology and Chemistry, Molecular Basis of Disease Program, Georgia State University, Atlanta, Georgia 30303, USA.

Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details
Protease	A, B	99	Human immunodeficiency virus 1, Human immunodeficiency virus type 1 group M subtype B (isolate BH5) This entity is chimeric	Mutation(s): 5  Gene Names: pol, gag-pol
Find proteins for Q7SSI0 (Human immunodeficiency virus 1) Go to UniProtKB:  Q7SSI0
Find proteins for P04587 (Human immunodeficiency virus type 1 group M subtype B (isolate BH5)) Go to UniProtKB:  P04587

Entity ID: 2
Molecule	Chains	Sequence Length	Organism	Details
peptide	C	5	N/A	Mutation(s): 0
Protein Feature View is not available: No corresponding UniProt sequence found.

Small Molecules

Ligands 3 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram & Interactions
NA	A	SODIUM ION Na FKNQFGJONOIPTF-UHFFFAOYSA-N
CL	A, B	CHLORIDE ION Cl VEXZGXHMUGYJMC-UHFFFAOYSA-M
GOL	B	GLYCEROL GLYCERIN; PROPANE-1,2,3-TRIOL C3 H8 O3 PEDCQBHIVMGVHV-UHFFFAOYSA-N

Biologically Interesting Molecules 1 Unique
ID	Chains	Name	Type/Class	2D Diagram	3D Interactions
PRD_000321	C	N-{(2S)-2-[(L-asparaginyl-L-leucyl)amino]-1,1-dihydroxy-4-methylpentyl}-L-threonyl-L-glutaminyl-L-isoleucine	Peptide-like / Inhibitor		--

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 1.46 Å
• R-Value Free: 0.212 
• Space Group: P 2₁ 2₁ 2

Unit Cell:

Length (Å)	Angle (°)
a = 58.304	α = 90.00
b = 86.121	β = 90.00
c = 46.307	γ = 90.00

Software Package:

Software Name	Purpose
SCALEPACK	data scaling
SHELXL-97	refinement
SHELX	model building
SHELX	phasing
MAR345	data collection

Structure Validation

Entry History 

Deposition Data

• Deposited Date: 2007-10-31 
• Released Date: 2007-12-18 
• Deposition Author(s): Kovalevsky, A.Y., Chumanevich, A.A., Weber, I.T.

Revision History 

• Version 1.0: 2007-12-18
  Type: Initial release
• Version 1.1: 2011-07-13
  Type: Atomic model, Database references, Derived calculations, Non-polymer description, Structure summary, Version format compliance
• Version 1.2: 2012-12-12
  Type: Other
• Version 1.3: 2017-10-25
  Type: Refinement description